Medicine
Eraxis 100 mg/30 mL powder for injection
Eraxis 100 mg/30 mL powder for injection is a prescription medicine containing Anidulafungin for intravenous use, marketed by Roerig, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. Excursions for 96 hours up to 25°C (77°F) are permitted, and…
Key facts
- Active ingredient (INN)
- Anidulafungin
- Brand
- Eraxis
- Strength
- 100 mg/30 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 15 mL, 30 mL, 1 vial
- Marketing authorisation holder
- Roerig
- Manufacturer
- Roerig
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Excursions for 96 hours up to 25°C (77°F) are permitted, and the vial can be returned to storage at 2°C – 8°C (36°F – 46°F). Do not freeze. Infusion Solution ERAXIS infusion solution can be stored at temperatures up to 25°C (77°F) for up to 48 hours. ERAXIS vials ERAXIS (unreconstituted) vials should be stored in a refrigerator at 2°C – 8°C (36°F – 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AX06 Anidulafungin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 February 2006
- Identifiers
- RxCUI 1804743, 1804746, 1804748 +1DailyMed set ID a88d9010-55fb-4a02-baff-042cd27688ea, d138ab10-1ed9-44be-8d81-49dda1e434acNDC 0049-0116, 0049-0114, 0049-2242Application NDA021632
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Anidulafungin is an echinocandin antifungal indicated for the treatment of infections, among other approved uses. It is available as powder for injection for intravenous use. MedsAcross supplies Anidulafungin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AnidulafunginFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ERAXIS prescribing information (Roerig) · U.S. National Library of Medicine, DailyMed
- Ecalta: European public assessment report (EPAR) · European Medicines Agency
Need Eraxis 100 mg/30 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.